Stora Enso Oyj (LON:0KCK)
100.67
-1.62 (-1.58%)
At close: Aug 1, 2025
Revance Therapeutics Market Cap
Stora Enso Oyj has a market cap or net worth of 6.25 billion as of August 1, 2025. Its market cap has decreased by -25.15% in one year.
Market Cap
6.25B
Enterprise Value
9.71B
Revenue
8.03B
Ranking
n/a
PE Ratio
n/a
Stock Price
$100.67
Market Cap Chart
Since May 3, 1996, Stora Enso Oyj's market cap has increased from 1.30B to 6.25B, an increase of 381.57%. That is a compound annual growth rate of 5.52%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 6.25B | -1.57% |
Dec 30, 2024 | 6.35B | -25.83% |
Dec 29, 2023 | 8.56B | -8.11% |
Dec 30, 2022 | 9.32B | -13.31% |
Dec 30, 2021 | 10.75B | -3.98% |
Dec 30, 2020 | 11.19B | 26.90% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 178.30B |
HSBC Holdings | 160.62B |
Shell | 157.43B |
Unilever | 111.06B |
British American Tobacco p.l.c. | 87.18B |
Rolls-Royce Holdings | 82.38B |
Rio Tinto Group | 78.40B |
RELX PLC | 71.47B |